These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 37758242)

  • 1. Update on Epithelial-Mesenchymal Plasticity in Cancer Progression.
    Fontana R; Mestre-Farrera A; Yang J
    Annu Rev Pathol; 2024 Jan; 19():133-156. PubMed ID: 37758242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.
    Garg M
    Cancer Metastasis Rev; 2022 Mar; 41(1):131-145. PubMed ID: 34978017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting approach on epithelial-mesenchymal plasticity to combat cancer metastasis.
    Mishra AB; Nishank SS
    Med Oncol; 2023 May; 40(7):190. PubMed ID: 37247000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition during mammalian neural crest cell delamination.
    Zhao R; Trainor PA
    Semin Cell Dev Biol; 2023 Mar; 138():54-67. PubMed ID: 35277330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.
    Bhatia S; Monkman J; Toh AKL; Nagaraj SH; Thompson EW
    Biochem J; 2017 Sep; 474(19):3269-3306. PubMed ID: 28931648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.
    Singh D; Siddique HR
    Cancer Metastasis Rev; 2024 Mar; 43(1):155-173. PubMed ID: 37775641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT Transition States during Tumor Progression and Metastasis.
    Pastushenko I; Blanpain C
    Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
    Williams ED; Gao D; Redfern A; Thompson EW
    Nat Rev Cancer; 2019 Dec; 19(12):716-732. PubMed ID: 31666716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets.
    Wang X; Xue X; Pang M; Yu L; Qian J; Li X; Tian M; Lyu A; Lu C; Liu Y
    MedComm (2020); 2024 Aug; 5(8):e659. PubMed ID: 39092293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
    Lu W; Kang Y
    Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
    Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
    Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression.
    Bhatia S; Wang P; Toh A; Thompson EW
    Front Mol Biosci; 2020; 7():71. PubMed ID: 32391381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression.
    Peng Z; Wang CX; Fang EH; Wang GB; Tong Q
    World J Gastroenterol; 2014 May; 20(18):5403-10. PubMed ID: 24833870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal plasticity-engaging stemness in an interplay of phenotypes.
    Chin VL; Lim CL
    Stem Cell Investig; 2019; 6():25. PubMed ID: 31559312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.
    Bornes L; Belthier G; van Rheenen J
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34072345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.
    Gupta PB; Pastushenko I; Skibinski A; Blanpain C; Kuperwasser C
    Cell Stem Cell; 2019 Jan; 24(1):65-78. PubMed ID: 30554963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
    Lee HM; Hwang KA; Choi KC
    Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic EMT: a multi-tool for tumor progression.
    Brabletz S; Schuhwerk H; Brabletz T; Stemmler MP
    EMBO J; 2021 Sep; 40(18):e108647. PubMed ID: 34459003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.